Literature DB >> 21174535

A global approach to inflammatory breast cancer.

Fredika M Robertson1, Massimo Cristofanilli.   

Abstract

Inflammatory breast cancer (IBC) is the most aggressive and deadly form of breast cancer. In spite of the comprehensive multidisciplinary approach to the management of this disease, the prognosis remains dismal. Moreover, there have been no major advancements in understanding the etiology and biology of IBC and no significant improvements in the diagnosis of the disease. The International Inflammatory Breast Cancer Conference was established in 2008 with the intention of creating a forum for the discussion, collaboration and development of proposals and working hypotheses. Furthermore, the conference represented an opportunity to raise awareness regarding IBC. The second international conference reported on several new exciting projects based on work from investigators and research teams devoted to making a difference in the fight against this disease.

Entities:  

Mesh:

Year:  2011        PMID: 21174535     DOI: 10.2217/fon.10.177

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  3 in total

1.  Survival Analysis of Patients with Inflammatory Breast Cancer in Relation to Clinical and Histopathological Characteristics.

Authors:  Marius Preda; Răzvan Ilina; Ovidiu Potre; Cristina Potre; Octavian Mazilu
Journal:  Cancer Manag Res       Date:  2020-12-03       Impact factor: 3.989

2.  The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism.

Authors:  Khoi Chu; Kimberley M Boley; Ricardo Moraes; Sanford H Barsky; Fredika M Robertson
Journal:  Oncotarget       Date:  2013-03

3.  Inflammatory Breast Cancer and Warm Antibody Autoimmune Hemolytic Anemia: A Rare Paraneoplastic Syndrome.

Authors:  Nene Ugoeke; Chidinma Onweni; Jennifer Treece; Vandana Pai; Sowminya Arikapudi; Evan Kulbacki; Kailash Bajaj
Journal:  J Investig Med High Impact Case Rep       Date:  2017-11-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.